–
Spero Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−88.0
FY22:
−42.2
FY23:
21.5
FY24:
−73.4
FY25:
6.31
(positive)
Change from FY21 to FY25
millions USD
FY21:
−89.8
FY22:
−46.4
FY23:
25.4
FY24:
−68.6
FY25:
8.83
(positive)
Change from FY21 to FY25
millions USD
FY21:
−89.8
FY22:
−46.4
FY23:
22.8
FY24:
−68.6
FY25:
8.57
All amounts in millions USD